Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Invested Capital: 2022-2025

Historic Return on Invested Capital for Puma Biotechnology (PBYI) over the last 3 years, with Sep 2025 value amounting to 0.23%.

  • Puma Biotechnology's Return on Invested Capital fell 6.00% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of 0.27% for FY2024, which is 30.00% down from last year.
  • Puma Biotechnology's Return on Invested Capital amounted to 0.23% in Q3 2025, which was down 29.63% from 0.32% recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Return on Invested Capital ranged from a high of 1.09% in Q1 2023 and a low of 0.00% during Q4 2022.
  • Over the past 3 years, Puma Biotechnology's median Return on Invested Capital value was 0.28% (recorded in 2024), while the average stood at 0.37%.
  • As far as peak fluctuations go, Puma Biotechnology's Return on Invested Capital soared by 41bps in 2023, and later slumped by 82bps in 2024.
  • Quarterly analysis of 4 years shows Puma Biotechnology's Return on Invested Capital stood at 0.00% in 2022, then surged by 41bps to 0.42% in 2023, then decreased by 18bps to 0.23% in 2024, then decreased by 6bps to 0.23% in 2025.
  • Its Return on Invested Capital was 0.23% in Q3 2025, compared to 0.32% in Q2 2025 and 0.26% in Q1 2025.